Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jose Juan Escobar-Barranco"'
Autor:
Alfredo García-Layana, Sergio Recalde, Maria Hernandez, Maximino J. Abraldes, João Nascimento, Emiliano Hernández-Galilea, Begoña Olmedilla-Alonso, Jose Juan Escobar-Barranco, Miguel Angel Zapata, Rufino Silva, Mariana Caballero Arredondo, María Carmen Lopez-Sabater, Silvia Mendez-Martínez, Nieves Pardiñas-Barón, Pilar Calvo, Patricia Fernández-Robredo
Publikováno v:
Nutrients, Vol 13, Iss 4, p 1253 (2021)
The purpose of this study is evaluate the efficacy and safety of medicinal products containing the original Age-Related Eye Disease group (AREDS) formulation at doses approved in Europe (EU, control group; n = 59) with a product that adds DHA, lutein
Externí odkaz:
https://doaj.org/article/37d0eb85e7bf4fd38ce0b27b78c01ba6
Autor:
David M. Brown, Andrés Emanuelli, Francesco Bandello, Jose Juan Escobar Barranco, João Figueira, Eric Souied, Sebastian Wolf, Vishali Gupta, Nor Fariza Ngah, Gerald Liew, Raman Tuli, Ramin Tadayoni, Dilsher Dhoot, Lixin Wang, Emmanuel Bouillaud, Ying Wang, Lidija Kovacic, Nicolas Guerard, Justus G. Garweg
Publikováno v:
Brown, David M; Emanuelli, Andrés; Bandello, Francesco; Barranco, Jose Juan Escobar; Figueira, João; Souied, Eric; Wolf, Sebastian; Gupta, Vishali; Ngah, Nor Fariza; Liew, Gerald; Tuli, Raman; Tadayoni, Ramin; Dhoot, Dilsher; Wang, Lixin; Bouillaud, Emmanuel; Wang, Ying; Kovacic, Lidija; Guerard, Nicolas; Garweg, Justus (2022). KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema. American journal of ophthalmology, 238, pp. 157-172. 10.1016/j.ajo.2022.01.004
PURPOSE To compare the efficacy and safety of brolucizumab with aflibercept in patients with diabetic macular edema (DME). DESIGN Double-masked, 100-week, multicenter, active-controlled, randomized trials. METHODS Subjects were randomized 1:1:1 to br
Autor:
Ruben Martin-Pinardel, Jordi Izquierdo-Serra, Sandro De Zanet, Alba Parrado-Carrillo, Gonzaga Garay-Aramburu, Martin Puzo, Carolina Arruabarrena, Laura Sararols, Maximino Abraldes, Laura Broc, Jose Juan Escobar-Barranco, Marta Figueroa, Miguel Angel Zapata, José M Ruiz-Moreno, Aina Moll-Udina, Carolina Bernal-Morales, Socorro Alforja, Marc Figueras-Roca, Laia Gómez-Baldó, Carlos Ciller, Stefanos Apostolopoulos, Agata Mosinska, Ricardo P Casaroli Marano, Javier Zarranz-Ventura
Publikováno v:
British Journal of Ophthalmology. :bjo-2022
AimTo explore associations between artificial intelligence (AI)-based fluid compartment quantifications and 12 months visual outcomes in OCT images from a real-world, multicentre, national cohort of naïve neovascular age-related macular degeneration
Autor:
Begoña Olmedilla-Alonso, Maria Hernandez, Alfredo García-Layana, Miguel A Zapata, Sergio Recalde, Maximino Abraldes, João Nascimento, Jose Juan Escobar-Barranco, M.C. López-Sabater, Silvia Mendez-Martinez, Rufino Silva, Pilar Calvo, Mariana Caballero Arredondo, Nieves Pardiñas-Barón, Patricia Fernandez-Robredo, Emiliano Hernández-Galilea
Publikováno v:
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Scientia
Nutrients, Vol 13, Iss 1253, p 1253 (2021)
Digital.CSIC: Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)
Digital.CSIC. Repositorio Institucional del CSIC
Nutrients
Volume 13
Issue 4
instname
Scientia
Nutrients, Vol 13, Iss 1253, p 1253 (2021)
Digital.CSIC: Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)
Digital.CSIC. Repositorio Institucional del CSIC
Nutrients
Volume 13
Issue 4
The purpose of this study is evaluate the efficacy and safety of medicinal products containing the original Age-Related Eye Disease group (AREDS) formulation at doses approved in Europe (EU, control group
n = 59) with a product that adds DHA, lu
n = 59) with a product that adds DHA, lu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::900fd947ba5d8f723e658c77a5a301c0
http://zaguan.unizar.es/record/118791
http://zaguan.unizar.es/record/118791